Human papillomavirus (HPV) is a group of related viruses that can infect the skin and mucous membranes of the genital area, mouth and throat. Although HPV infections are common, their effects vary depending on the type of virus involved. Some types primarily cause genital warts, while others can lead to changes in cells that may eventually develop into cancer.
Most HPV infections cause no noticeable symptoms and resolve naturally as the immune system controls the infection. However, certain infections can persist and require medical monitoring. Understanding the differences between hpv types helps explain why some infections cause visible growths, while others may remain unnoticed until abnormal cellular changes are identified during screening.
Understanding how these viruses behave also helps people appreciate the importance of vaccination, appropriate screening, and timely medical assessment.
What Are the Different Types of HPV and How Are They Classified?
More than 200 HPV types have been identified, including approximately 40 that can infect the genital area. These viruses are classified according to their association with benign conditions or cancer.
Low-risk HPV types are primarily associated with genital warts and other benign growths. HPV 6 and HPV 11 cause about 90% of anogenital warts. These types are not associated with HPV-related cancers.
High-risk HPV types, also known as oncogenic types, can cause persistent infections that lead to abnormal changes in infected cells. If these changes progress without appropriate detection and treatment, some may develop into cancer.
HPV 16 and HPV 18 are particularly important because they account for a substantial proportion of cervical cancer cases. Other high-risk types include HPV 31, 33, 35, 39, 45, 51, 52, 56 and 58, among others.
The distinction between these groups matters, but it does not mean every infection causes symptoms or leads to disease. Many infections resolve naturally, including infections with high-risk types. Persistent high-risk infection is the main concern because it is associated with precancerous cellular changes.
Which HPV Types Are Most Commonly Associated With Genital Warts?
Genital warts are benign growths that appear on or around the genitals or anus. They may develop as individual bumps or clusters, with appearances ranging from small, flat lesions to raised growths. Depending on their size and location, they may cause itching, irritation or discomfort, although many are painless.
HPV 6 and HPV 11 cause most genital warts. These low-risk types primarily affect the skin and mucous membranes rather than producing the cellular changes associated with most HPV-related cancers.
Genital warts can develop on the vulva, around the vaginal opening, on the penis, around the scrotum or on the skin surrounding the anus. They may also occur inside the vagina, on the cervix or within the anal canal.
The timing of their appearance varies. Warts may become visible months or even years after infection, so their presence does not reliably indicate when the virus was acquired. Some people carry the virus without ever developing visible growths.
HPV 6 and HPV 11 are also associated with recurrent respiratory papillomatosis, a rare condition in which benign, wart-like growths develop in the respiratory tract, particularly the larynx. These growths can affect the voice and, in some cases, interfere with breathing.
Although genital warts are benign, unusual, persistent, bleeding or rapidly changing growths should be examined by a healthcare professional. Other conditions can resemble warts, and a biopsy may be necessary when the diagnosis is uncertain or a lesion appears atypical.
How Do High-Risk HPV Types Differ From Low-Risk Types?
The main difference between high-risk and low-risk HPV types lies in their association with cellular changes and cancer.
Low-risk types, particularly HPV 6 and HPV 11, are responsible for most genital warts. High-risk types can interfere with normal cellular regulation, allowing abnormal cells to develop and sometimes multiply over time.
HPV 16 and HPV 18 are strongly associated with cervical cancer. Other high-risk types also contribute to cervical cancer and certain cancers affecting the anus, vulva, vagina, penis and oropharynx, which includes the tonsils and base of the tongue.
Persistent infection is particularly important. When the immune system does not control a high-risk infection, abnormal cellular changes may develop over several years. Some changes resolve naturally, while others can progress to precancerous lesions and, in certain cases, cancer.
However, a positive high-risk HPV test does not mean that a person has cancer or will necessarily develop it. The result indicates an infection that may require follow-up based on the individual’s test results and clinical circumstances.
Similarly, having genital warts does not automatically mean that a person has a cancer-causing HPV type. The types responsible for most genital warts differ from those responsible for most HPV-related cancers, although more than one type can be present at the same time.
What Other Health Conditions Can Be Associated With HPV?
HPV is associated with several health conditions beyond genital warts and cervical cancer. Risks depend on the virus type, the affected tissue, and whether the infection persists.
Cervical cell abnormalities and cervical cancer
Persistent high-risk HPV infection can cause abnormal changes in cervical cells. Cervical screening may detect these changes before cancer develops.
Not every abnormal result indicates a serious problem. Some cellular changes resolve on their own, while others require closer monitoring or treatment. The appropriate approach depends on the abnormality’s type and severity.
HPV 16 and HPV 18 are responsible for a substantial proportion of cervical cancers, although other high-risk types can also cause the disease.
Anal cancer
Certain high-risk types can cause persistent cellular changes in the anal region, increasing the risk of anal cancer.
Symptoms include anal bleeding, pain, a lump or persistent discomfort. These symptoms can have several causes, so medical assessment is needed to determine their origin.
Vulvar and vaginal cancers
Persistent high-risk HPV infection is associated with some cancers of the vulva and vagina. A healthcare professional should assess unusual skin changes, persistent itching, a lump, or unexplained discomfort, especially if symptoms do not resolve.
Not all vulvar or vaginal cancers are caused by HPV, and similar symptoms may occur with non-cancerous conditions.
Penile cancer
Some high-risk HPV types are associated with penile cancer. Although this cancer is uncommon, persistent HPV infection is a recognised risk factor.
A persistent sore, lump, unusual skin change or area of thickening on the penis warrants medical evaluation.
Oropharyngeal cancer
High-risk HPV types, particularly HPV 16, are associated with some cancers affecting the tonsils and base of the tongue. These infections may not cause noticeable symptoms early on.
Persistent throat discomfort, difficulty swallowing, ongoing voice changes, or a lump in the neck should be evaluated by a doctor. Such symptoms do not, by themselves, establish an HPV infection or cancer diagnosis.
Can a Person Have More Than One HPV Type at the Same Time?
Yes. A person can have multiple HPV infections simultaneously. For example, someone may carry a low-risk type associated with genital warts and a high-risk type associated with cervical cell abnormalities.
One type does not prevent infection with another. Likewise, visible genital warts cannot establish which other types may be present, and the absence of warts does not rule out a high-risk infection.
HPV can also remain undetected for an extended period. A positive result does not reliably establish when the infection began or identify when or from whom it was acquired.
For this reason, an HPV diagnosis should be approached as a health matter rather than evidence of recent transmission or infidelity.
How Does the Immune System Respond to Different HPV Types?
The immune system plays a significant role in determining the outcome of an HPV infection. Most infections become undetectable naturally, often within one or two years, without causing lasting health problems.
However, some infections persist. Persistent high-risk infections are more concerning because they can lead to abnormal cellular changes over time. People with weakened immune systems may be more likely to experience persistent infection or HPV-related complications.
The absence of symptoms does not mean HPV is absent. High-risk infections can go unnoticed, which is why cervical screening matters.
It is also essential to distinguish between treating an HPV-related condition and eliminating the virus. Treatments are available for genital warts and precancerous lesions, but they do not necessarily remove HPV from the body. Warts may recur after treatment, and follow-up may be required for certain cellular abnormalities.
How Can HPV-Related Health Risks Be Reduced?
Several preventive measures can reduce the risk of HPV infection and its associated complications.
HPV vaccination
HPV vaccination protects against selected types responsible for many cases of genital warts and HPV-related cancers. Vaccination provides the greatest benefit when administered before exposure to the virus.
Eligibility and recommendations depend on age, vaccination history and applicable medical guidelines. The vaccine prevents new infections with targeted types but does not treat an existing infection or eliminate HPV already present in the body.
Cervical screening
Cervical screening can identify high-risk HPV infections or abnormal cervical cells before cancer develops. Depending on the screening programme, this may involve HPV testing, cervical cytology or a combination of methods.
People should follow the screening recommendations applicable to their age and medical circumstances. An abnormal result does not automatically indicate cancer, but it may require repeat testing, further investigation or treatment.
Routine screening recommendations differ for other HPV-associated cancers. People with relevant symptoms or individual risk factors should discuss appropriate assessment with a healthcare professional.
Safer sexual practices
HPV spreads through intimate skin-to-skin contact, including sexual contact. Condoms can reduce the risk of transmission, but they do not provide complete protection because HPV can affect areas of skin they do not cover.
The absence of visible warts does not guarantee that a person cannot transmit HPV. Understanding this helps individuals make informed decisions about sexual health and preventive care.
Medical assessment of unusual symptoms
Persistent genital growths, unexplained skin changes, unusual bleeding or other concerning symptoms should be assessed by a qualified healthcare professional.
Genital warts are usually diagnosed through visual examination. A biopsy may be necessary when lesions appear atypical, the diagnosis is uncertain or the growths do not respond to treatment.
HPV testing is not recommended to diagnose genital warts because the results do not confirm the cause of an individual growth or guide treatment.
Why Is Understanding HPV Types Important for Long-Term Health?
Understanding hpv types helps explain why some infections cause genital warts while others are associated with precancerous changes and cancer. It also clarifies why the absence of visible symptoms cannot rule out infection and why preventive healthcare remains important.
Low-risk types, particularly HPV 6 and HPV 11, cause most genital warts. High-risk types, including HPV 16 and HPV 18, are associated with cervical cancer and other HPV-related cancers. However, most HPV infections do not lead to serious illness, and even a high-risk infection does not automatically result in cancer.
Vaccination, appropriate cervical screening and timely medical assessment can help reduce the health consequences of HPV. Understanding the differences between these infections allows people to make informed decisions about prevention, recognise when medical advice is needed and approach HPV-related health concerns with accurate information rather than unnecessary fear.